TY - JOUR
T1 - An international registry for primary ciliary dyskinesia
AU - Werner, Claudius
AU - Lablans, Martin
AU - Ataian, Maximilian
AU - Raidt, Johanna
AU - Wallmeier, Julia
AU - Große-Onnebrink, Jörg
AU - Kuehni, Claudia E.
AU - Haarman, Eric G.
AU - Leigh, Margaret W.
AU - Quittner, Alexandra L.
AU - Lucas, Jane S.
AU - Hogg, Claire
AU - Witt, Michal
AU - Priftis, Kostas N.
AU - Yiallouros, Panayiotis
AU - Nielsen, Kim G.
AU - Santamaria, Francesca
AU - Ückert, Frank
AU - Omran, Heymut
N1 - Publisher Copyright:
© ERS 2016.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Primary ciliary dyskinesia (PCD) is a rare autosomal recessive disorder leading to chronic upper and lower airway disease. Fundamental data on epidemiology, clinical presentation, course and treatment strategies are lacking in PCD. We have established an international PCD registry to realise an unmet need for an international platform to systematically collect data on incidence, clinical presentation, treatment and disease course. The registry was launched in January 2014. We used internet technology to ensure easy online access using a web browser under www.pcdregistry.eu. Data from 201 patients have been collected so far. The database is comprised of a basic data form including demographic and diagnostic information, and visit forms designed to monitor the disease course. To establish a definite PCD diagnosis, we used strict diagnostic criteria, which required two to three diagnostic methods in addition to classical clinical symptoms. Preliminary analysis of lung function data demonstrated a mean annual decline of percentage predicted forced expiratory volume in 1 s of 0.59% (95% CI 0.98-0.22). Here, we present the development of an international PCD registry as a new promising tool to advance the understanding of this rare disorder, to recruit candidates for research studies and ultimately to improve PCD care.
AB - Primary ciliary dyskinesia (PCD) is a rare autosomal recessive disorder leading to chronic upper and lower airway disease. Fundamental data on epidemiology, clinical presentation, course and treatment strategies are lacking in PCD. We have established an international PCD registry to realise an unmet need for an international platform to systematically collect data on incidence, clinical presentation, treatment and disease course. The registry was launched in January 2014. We used internet technology to ensure easy online access using a web browser under www.pcdregistry.eu. Data from 201 patients have been collected so far. The database is comprised of a basic data form including demographic and diagnostic information, and visit forms designed to monitor the disease course. To establish a definite PCD diagnosis, we used strict diagnostic criteria, which required two to three diagnostic methods in addition to classical clinical symptoms. Preliminary analysis of lung function data demonstrated a mean annual decline of percentage predicted forced expiratory volume in 1 s of 0.59% (95% CI 0.98-0.22). Here, we present the development of an international PCD registry as a new promising tool to advance the understanding of this rare disorder, to recruit candidates for research studies and ultimately to improve PCD care.
UR - http://www.scopus.com/inward/record.url?scp=84959895699&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959895699&partnerID=8YFLogxK
U2 - 10.1183/13993003.00776-2015
DO - 10.1183/13993003.00776-2015
M3 - Article
C2 - 26659107
AN - SCOPUS:84959895699
VL - 47
SP - 849
EP - 859
JO - The European respiratory journal
JF - The European respiratory journal
SN - 0903-1936
IS - 3
ER -